These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6407404)

  • 21. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: implications for nursing care.
    Sittlington N; Tubman R; Halliday HL
    Midwifery; 1991 Mar; 7(1):20-4. PubMed ID: 2011088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in respiratory compliance after surfactant therapy evaluated by a new method.
    Nikischin W; Brendel-Müller K; Viemann M; Oppermann H; Schaub J
    Pediatr Pulmonol; 2000 Apr; 29(4):276-83. PubMed ID: 10738015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin A is systemically bioavailable after intratracheal administration with surfactant in an animal model of newborn respiratory distress.
    Singh AJ; Bronshtein V; Khashu M; Lee K; Potts JE; Friel J; Chessex P
    Pediatr Res; 2010 Jun; 67(6):619-23. PubMed ID: 20216104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
    Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T
    N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
    Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
    Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in dead space/tidal volume ratio and pulmonary mechanics after surfactant replacement therapy in respiratory distress syndrome of the newborn infants.
    Chung EH; Ko SY; Kim IY; Chang YS; Park WS
    J Korean Med Sci; 2001 Feb; 16(1):51-6. PubMed ID: 11289401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How does exogenous surfactant work?
    Milner AD
    Arch Dis Child; 1993 Mar; 68(3 Spec No):253-4. PubMed ID: 8466258
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthetic surfactant replacement therapy decreases estimated pulmonary artery pressure in respiratory distress syndrome.
    Kääpä P; Kero P; Saraste M
    Am J Dis Child; 1992 Aug; 146(8):961-4. PubMed ID: 1636665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of surfactant in the treatment of acute respiratory distress syndrome in a child].
    Fraisse A; Paut O; Silicani MA; Viard L; Camboulives J
    Arch Pediatr; 1996 Sep; 3(9):891-5. PubMed ID: 8949353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratracheal atomized surfactant provides similar outcomes as bolus surfactant in preterm lambs with respiratory distress syndrome.
    Milesi I; Tingay DG; Zannin E; Bianco F; Tagliabue P; Mosca F; Lavizzari A; Ventura ML; Zonneveld CE; Perkins EJ; Black D; Sourial M; Dellacá RL
    Pediatr Res; 2016 Jul; 80(1):92-100. PubMed ID: 26954481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant in the perinatal period.
    Jobe AH
    Early Hum Dev; 1992; 29(1-3):57-62. PubMed ID: 1396280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate changes in lung compliance following natural surfactant administration in premature infants with respiratory distress syndrome: a controlled trial.
    Attar MA; Becker MA; Dechert RE; Donn SM
    J Perinatol; 2004 Oct; 24(10):626-30. PubMed ID: 15201857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.
    Merritt TA; Hallman M; Spragg R; Heldt GP; Gilliard N
    Drugs; 1989 Oct; 38(4):591-611. PubMed ID: 2684594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of artificial surfactant on pulmonary function in preterm and full-term lambs.
    Gladstone IM; Ray AO; Salafia CM; Pérez-Fontán J; Mercurio MR; Jacobs HC
    J Appl Physiol (1985); 1990 Aug; 69(2):465-72. PubMed ID: 2121700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous surfactant in acute respiratory distress syndrome: more is better.
    Anzueto A
    Eur Respir J; 2002 May; 19(5):787-9. PubMed ID: 12030713
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant].
    Speer CP; Harms K; Müller U; Schröter W; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):65-70. PubMed ID: 3130571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of preterm infants receiving surfactant supplementation.
    Bevilacqua G; Gaioni L; Parmigiani S
    Eur Respir J Suppl; 1989 Mar; 3():87s-90s. PubMed ID: 2742686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of single-dose surfactant TA therapy for premature infants with severe respiratory distress syndrome.
    Deng HH; Kuo MC; Chung KH; Hsu HH; Lin ST
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(6):408-16. PubMed ID: 1306925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.